ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Based on recent data, Abbott Laboratories (ABT) shows an Average True Range (ATR) of 2.82 and an Enterprise Value of 192.75B. Its average trading volume over the past 3 months is 6.73M, indicating liquidity. These fundamental metrics provide insight into ABT's underlying financial health and market activity.
Abbott Laboratories (ABT) technical indicators as of July 31, 2025: the SMA 20 is -0.54%, SMA 50 at -2.71%, and SMA 200 at 2.3%. The RSI 14 value is 47.12, suggesting its current momentum. These technical analysis signals help assess ABT's price trends and potential future movements.
Abbott Laboratories (ABT) stock performance overview as of July 31, 2025: The 52-week high is $141.23 (currently -8.98% below), and the 52-week low is $106.33 (currently 25.07% above). Over the past year, ABT's performance is 21.32%, compared to the S&P 500's 17.04% change.
According to market data, Abbott Laboratories (ABT) stock's recent performance metrics show that over the last month, ABT is -5.48%, with a Year-to-Date (YTD) performance of 13.65%. Over the past year, the stock has seen a 21.32% change. These figures summarize ABT's price movements across various periods, reflecting its historical returns.
According to current financial data, ABT stock's P/E (TTM) ratio is 15.98, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ABT, including P/S (5.19), P/B (4.58), and P/FCF (33.59), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep